ABVC vs REG · rev $509.6K vs P/E 34, $12.93B cap
ABVC Biopharma Inc (ABVC) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
REG does not have a complete income-statement cache yet.
ABVC currently screens at market cap $35.9M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ABVC and REG stock pages for the full models.
Not investment advice.